Adi Dagan

5PUBLICATIONS
10CO-AUTHORS
Infant and child healthMedical devicesEpidemiological modellingMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 18, 2026
Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2-6 With Cystic Fibrosis.

Adi Dagan, Mohamad Hadhud, Ori Efrati

|Feb 13, 2025
A Novel Medical Device for Airway Clearance.

Nir Helper, Moshe Ashkenazi, Gil Sokol

|Jul 25, 2024
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study.

Karin Yaacoby-Bianu, Adi Dagan, Malena Cohen-Cymberknoh

|Mar 05, 2022
Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.

Guy Chowers, Gadi Abebe-Campino, Hana Golan

|May 25, 2016
Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.

Daphna Vilozni, Moran Lavie, Miryam Ofek

Pageof 1

Frequent Collaborators

2 joint publications

Malena Cohen-Cymberknoh

1 joint publications

Daphna Vilozni

1 joint publications

Moran Lavie

1 joint publications

Miryam Ofek